CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses
WOONSOCKET, RHODE ISLAND, JUL 31 – Analysts hold mixed views on CVS Health's Q2 results, with earnings expected at $1.46 per share and revenue rising to $94.59 billion, reflecting varied price target adjustments.
- CVS Health reported second-quarter 2025 earnings on July 31, showing adjusted EPS of $1.81 and revenue of $98.9 billion, both exceeding estimates.
- The report followed a background of leadership changes with David Joyner as CEO, ongoing transformation, and elevated medical costs pressuring the insurance unit.
- Revenue rose 8.4% year-over-year, driven by strong pharmacy and consumer wellness sales up 12%, while the insurance segment grew 11% despite higher medical benefit ratios.
- Joyner attributed the earnings outperformance to advancements in pharmacy reimbursement and care delivery, highlighting the company’s continued achievement of strong financial performance for several quarters in a row.
- CVS raised its outlook for adjusted earnings per share in fiscal 2025 to a range of $6.30 to $6.40, boosted its revenue projections, and aims to reduce costs by $2 billion, reflecting strong confidence despite challenges in the industry.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles

+4 Reposted by 4 other sources
CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses
CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health care giant continued to rally under new management from a forgettable 2024.
·United States
Read Full ArticleCVS Health Hikes 2025 Forecast Again, Boosted by Insurance, Pharmacy Businesses
CVS Health topped Wall Street expectations for the second quarter and hiked its full-year forecast again, as the health care giant continued to rally under new management from a forgettable 2024.
·New York, United States
Read Full Article

CVS shares pop on earnings beat and outlook, as retail pharmacy and insurance units improve
CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is grappling with higher medical costs.
·Chicago, United States
Read Full ArticleCoverage Details
Total News Sources14
Leaning Left3Leaning Right0Center6Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium